MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis by Stefano Alivernini, Elisa Gremese, Charles McSharry, Barbara Tolusso, Gianfranco Ferraccioli, Iain B. McInnes, Iain B. McInnes, Mariola Kurowska-Stolarska, Mariola Kurowska-Stolarska

Get full text

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways by Hanna Johnsson, John Cole, Stefan Siebert, Iain B. McInnes, Gerard Graham

Get full text

Time-varying risks of infection in patients as they proceed through the phases of ‘pre-RA’: results from the Scottish Early RA inception cohort by Iain B McInnes, Duncan Porter, Sahil Jain, Evelyn Qian, Fraser R Morton

Get full text

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes by Iain B McInnes, Philip S Helliwell, Laura M Sawyer, Corinne LeReun, Kristen Markus, Celia Sabry-Grant

Get full text

Th17 effector cells support B cell responses outside of germinal centres. by Agapitos Patakas, Robert A Benson, David R Withers, Paola Conigliaro, Iain B McInnes, James M Brewer, Paul Garside

Get full text

Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre by Ronald F van Vollenhoven, Anna Molto, Iain B McInnes, Rik Lories, Andrew Cope, Dirk Elewaut, Katja Reuter, Carina Haupt

Get full text

Identification of urinary peptide biomarkers associated with rheumatoid arthritis. by Angelique Stalmach, Hanna Johnsson, Iain B McInnes, Holger Husi, Julie Klein, Mohammed Dakna, William Mullen, Harald Mischak, Duncan Porter

Get full text

JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation by Iain B McInnes, Duncan Porter, Stefan Siebert, Carl S Goodyear, Jagtar Singh Nijjar, Derek S Gilchrist, Marina Frleta-Gilchrist, Mukanthu H Nyirenda

Get full text

Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis by Claudio Carini, Ewan Hunter, Scottish Early Rheumatoid Arthritis Inception cohort Investigators, Aroul S. Ramadass, Jayne Green, Alexandre Akoulitchev, Iain B. McInnes, Carl S. Goodyear

Get full text

Sphingosine-1-Phosphate Promotes the Persistence of Activated CD4 T Cells in Inflamed Sites by Shafqat Ahrar Jaigirdar, Robert A. Benson, Aziza Elmesmari, Mariola Stefania Kurowska-Stolarska, Iain B. McInnes, Paul Garside, Megan K. L. MacLeod

Get full text

Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation by Rónán Daly, Gavin Blackburn, Cameron Best, Carl S. Goodyear, Manikhandan Mudaliar, Karl Burgess, Anne Stirling, Duncan Porter, Iain B. McInnes, Michael P. Barrett, James Dale

Get full text

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study by Iain B. McInnes, Koji Kato, Marina Magrey, Joseph F. Merola, Mitsumasa Kishimoto, Derek Haaland, Liang Chen, Yuanyuan Duan, Jianzhong Liu, Ralph Lippe, Peter Wung

Get full text

In Human Autoimmunity, a Substantial Component of the B Cell Repertoire Consists of Polyclonal, Barely Mutated IgG+ve B Cells by Graeme J. M. Cowan, Katherine Miles, Lorenzo Capitani, Sophie S. B. Giguere, Sophie S. B. Giguere, Hanna Johnsson, Carl Goodyear, Iain B. McInnes, Steffen Breusch, David Gray, Mohini Gray

Get full text

Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase... by Laura C. Coates, Proton Rahman, Philip J. Mease, May Shawi, Emmanouil Rampakakis, Alexa P. Kollmeier, Xie L. Xu, Soumya D. Chakravarty, Iain B. McInnes, Lai-Shan Tam

Get full text

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis by Peter Nash, Iain B McInnes, Ernest Choy, Jeffrey R Curtis, Eduardo Mysler, Christina Charles-Schoeman, Nasser Khan, Kunihiro Yamaoka, Ralph Lippe, Hannah Palac, Anna K Shmagel, Jessica Suboticki

Get full text

Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, plac... by Philip J Mease, Shihong Sheng, Iain B McInnes, Alice B Gottlieb, Proton Rahman, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, May Shawi, Frédéric Lavie

Get full text

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3) by Peter Nash, Philip J. Mease, Iain B. McInnes, Proton Rahman, Christopher T. Ritchlin, Ricardo Blanco, Eva Dokoupilova, Mats Andersson, Radhika Kajekar, Shephard Mpofu, Luminita Pricop, on behalf of the FUTURE 3 study group

Get full text

Fibroblast activation and inflammation in frozen shoulder. by Moeed Akbar, Michael McLean, Emma Garcia-Melchor, Lindsay An Crowe, Paul McMillan, Umberto G Fazzi, David Martin, Angus Arthur, James H Reilly, Iain B McInnes, Neal L Millar

Get full text

Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis by Jeffrey R. Curtis, Iain B. McInnes, Proton Rahman, Dafna D. Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P. Kollmeier, Natalie J. Shiff, Chenglong Han, May Shawi, William Tillett, Philip J. Mease

Get full text

Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studi... by Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, May Shawi, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Stephen Xu, Christopher T. Ritchlin, Proton Rahman, Phillip J. Mease

Get full text